| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/28/2011 | WO2011091167A2 Lysophosphatidic acid receptor targeting for scleroderma and other fibrotic diseases |
| 07/28/2011 | WO2011091164A1 Oral dosage forms having a high loading of a tranexamic acid prodrug |
| 07/28/2011 | WO2011091122A1 Methods for internally controlling or treating equine bot larvae |
| 07/28/2011 | WO2011091065A2 Synthetic nanostructures including nucleic acids and/or other entities |
| 07/28/2011 | WO2011091000A2 Oral care compositions and methods |
| 07/28/2011 | WO2011090965A1 Novel cationic lipids for oligonucleotide delivery |
| 07/28/2011 | WO2011090932A2 A method of treating sinusitis, including chronic sinusitis |
| 07/28/2011 | WO2011090725A2 Gastroretentive solid oral dosage forms with swellable hydrophilic polymer |
| 07/28/2011 | WO2011090724A2 Gastroretentive solid oral dosage forms with lipid-based low-density excipient |
| 07/28/2011 | WO2011090694A1 Orally administrable film dosage forms containing ondansetron |
| 07/28/2011 | WO2011090349A2 Nanocarrier having enhanced skin permeability, cellular uptake and tumour delivery properties |
| 07/28/2011 | WO2011090306A2 Liquid formulations for long-acting erythropoietin conjugate |
| 07/28/2011 | WO2011090305A2 Liquid formulations for long-acting g-csf conjugate |
| 07/28/2011 | WO2011090088A1 Solution preparation containing stabilized antibody |
| 07/28/2011 | WO2011089604A2 Material and method for treating internal cavities |
| 07/28/2011 | WO2011089395A1 Antiseptic chewing gum |
| 07/28/2011 | WO2011089234A2 Method and composition |
| 07/28/2011 | WO2011088820A1 Solid pharmaceutical composition comprising lercanidipine |
| 07/28/2011 | WO2011088751A1 A human factor ix slow release dosage form |
| 07/28/2011 | WO2011088745A1 Ophthalmic external antibacterial medicine |
| 07/28/2011 | WO2011088715A1 Use of albiflorin for anti-parkinson's disease |
| 07/28/2011 | WO2011088688A1 Polymer micelle medicine carrier comprising amino acid as stabilizer |
| 07/28/2011 | WO2011088553A1 Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof |
| 07/28/2011 | WO2011088550A1 Pharmaceutical formulations of loratadine for encapsulation and combinations thereof |
| 07/28/2011 | WO2011088532A1 Pharmaceutical compositions for the treatment of bacterial infections |
| 07/28/2011 | WO2011069075A3 Treating impulse control disorders with catechol-o- methyl-transferase inhibitors |
| 07/28/2011 | WO2011060065A3 Instillation of liposomal formulation of sirna and antisense oligonucleotides |
| 07/28/2011 | WO2011049706A9 Orally transformable tablets |
| 07/28/2011 | WO2011031617A3 Seamless alginate capsules |
| 07/28/2011 | WO2011031462A3 Compositions for delivery of insoluble agents |
| 07/28/2011 | WO2011009991A3 Dendritic pic micelles with bioactive proteins |
| 07/28/2011 | WO2011002239A9 Microvesicles derived from nucleated, mammalian cells and use thereof |
| 07/28/2011 | WO2010140061A3 Formulations for the treatment of deep tissue pain |
| 07/28/2011 | WO2010119300A9 Oral suspension of dexamethasone acetate -taste masking composition of dexamethasone |
| 07/28/2011 | WO2009101110A8 Method for manufacturing mesoporous materials, materials so produced and use of mesoporous materials |
| 07/28/2011 | WO2008137733A3 Micellar structures, methods of making micellar structures, methods of imaging, and methods of delivering agents |
| 07/28/2011 | US20110184381 Repair of defects or lesions in cartilage and bone using a chondro-regulative matrix |
| 07/28/2011 | US20110184358 Pulsatile peri-corneal drug delivery device |
| 07/28/2011 | US20110184356 Biomolecular wearable apparatus |
| 07/28/2011 | US20110184069 Methods and compositions for administration of trpv1 agonists |
| 07/28/2011 | US20110183126 Substrate Marking |
| 07/28/2011 | US20110183020 Preparation, process and a regenerative method and technique for prevention, treatment and glycemic control of diabetes mellitus |
| 07/28/2011 | US20110182999 Ceramide dispersion and method for producing same |
| 07/28/2011 | US20110182998 Microspheres useful for therapeutic vascular embolization |
| 07/28/2011 | US20110182997 Suspension formulations |
| 07/28/2011 | US20110182996 Surface modified nanoparticles, methods of their preparation, and uses thereof for gene and drug delivery |
| 07/28/2011 | US20110182995 Medical and dental biomaterial and method of use for the same |
| 07/28/2011 | US20110182994 Methods and systems for production of nanoparticles |
| 07/28/2011 | US20110182993 Film-form preparation |
| 07/28/2011 | US20110182992 Peptides and peptide mimetics to treat pathologies associated with eye disease |
| 07/28/2011 | US20110182991 Method for improved fibrin sealing |
| 07/28/2011 | US20110182989 Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic agents to rgd binding sites |
| 07/28/2011 | US20110182988 Gastroretentive pharmaceutical dosage form |
| 07/28/2011 | US20110182987 Pharmaceutical dosage form for the site-specific delivery of more than one active pharmaceutical ingredient |
| 07/28/2011 | US20110182986 Controlled release composition |
| 07/28/2011 | US20110182985 Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof |
| 07/28/2011 | US20110182984 High Content Sodium Ibuprofen Granules, Their Preparation And Their Use In Preparing Non-Effervescent Solid Dosage Forms |
| 07/28/2011 | US20110182983 Human immortalised neural precursor cell line |
| 07/28/2011 | US20110182982 Liposome treatment of viral infections |
| 07/28/2011 | US20110182981 Gonococcal vaccines |
| 07/28/2011 | US20110182980 Composition for suppressing expression of target gene |
| 07/28/2011 | US20110182979 In-Vivo Non-Viral Gene Delivery of Human Vascular Endothelial Growth Factor Following Islet Transplantation |
| 07/28/2011 | US20110182978 Activated nitric oxide donors and methods of making and using thereof |
| 07/28/2011 | US20110182977 Topical composition containing ibuprofen |
| 07/28/2011 | US20110182976 Lipoplex-patch based dna vaccine |
| 07/28/2011 | US20110182975 Method of conferring a protective immune response to norovirus |
| 07/28/2011 | US20110182974 Multimeric multiepitope influenza vaccines |
| 07/28/2011 | US20110182973 Polymerase inhibitors and the use thereof for the treatment of tumors |
| 07/28/2011 | US20110182972 Low-concentration capsaicin patch and methods for treating neuropathic pain |
| 07/28/2011 | US20110182970 Nitric oxide sensors and systems |
| 07/28/2011 | US20110182969 Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
| 07/28/2011 | US20110182968 Interpenetrating polymer network hydrogel corneal prosthesis |
| 07/28/2011 | US20110182967 Implants for administering substances and methods of producing implants |
| 07/28/2011 | US20110182966 Intracameral sustained release therapeutic agent implants |
| 07/28/2011 | US20110182964 Vascular Stent Which Elutes Amino Acid-Methyl-Ester Derivatives for the Treatment of Vulnerable Plaque and Vascular Disease |
| 07/28/2011 | US20110182961 Osteogenic cell delivery matrix |
| 07/28/2011 | US20110182957 Cellulosics for tissue replacement |
| 07/28/2011 | US20110182954 Orally-administered agent |
| 07/28/2011 | US20110182953 Polymorphic form of calcium acamprosate |
| 07/28/2011 | US20110182952 Drug delivery from embolic agents |
| 07/28/2011 | US20110182950 Combination of blood and of biphasic calcium phosphate ceramic particles |
| 07/28/2011 | US20110182949 Stabilized transdermal drug delivery system |
| 07/28/2011 | US20110182948 Method for treating disease characterized by plaque |
| 07/28/2011 | US20110182947 Hydrogel-driven drug dosage form |
| 07/28/2011 | US20110182946 Formation of Nanostructured Particles of Poorly Water Soluble Drugs and Recovery by Mechanical Techniques |
| 07/28/2011 | US20110182864 Compositions containing inclusion complexes |
| 07/28/2011 | US20110182857 Delivery of Drugs to Mucosal Surfaces |
| 07/28/2011 | US20110182831 Systems and methods used in conjunction with nicotine vaccines for effecting cessation of tobacco use |
| 07/28/2011 | US20110182830 Inhalation drug products, systems and uses |
| 07/28/2011 | US20110182829 Methods of stimulating immune response in virally infected individuals |
| 07/28/2011 | US20110182824 Method and dosage form to confirm compliant use of a bioactive agent |
| 07/28/2011 | US20110182807 Method and Dosage Form to Confirm Compliant Use of a Bioactive Agent |
| 07/28/2011 | US20110182806 Systems and methods for particle radiation enhanced delivery of therapy |
| 07/28/2011 | US20110182805 Nanoparticle fabrication methods, systems, and materials |
| 07/28/2011 | US20110180249 Method for surface treating a heat exchanger, surface treatment agent, and aluminum heat exchanger |
| 07/28/2011 | CA2787652A1 Liquid formulations for long-acting erythropoietin conjugate |
| 07/28/2011 | CA2787648A1 Liquid formulations for long-acting g-csf conjugate |
| 07/28/2011 | CA2787573A1 Alpha-2 adrenergic agonist having long duration of intraocular pressure-lowering effect |
| 07/28/2011 | CA2787514A1 Intracameral sustained release therapeutic agent implants |
| 07/28/2011 | CA2787512A1 A method of treating sinusitis, including chronic sinusitis |